New Competition Brings Innovation to Diabetes Management

A new competition to bring innovation into the daily lives of type 2 diabetes patients was launched on April 10.

The Alexa Diabetes Challenge is calling on innovators to create Alexa voice-enabled solutions to improve the lives of those with type 2 diabetes. The $250,000, multi-stage, prize competition is sponsored by Merck & Co., and supported by Amazon Web Services (AWS). The Challenge is powered by Luminary Labs.

An estimated 27.5 million people live with type 2 diabetes in the U.S. Thanks to greater awareness and better treatments, many who have been diagnosed with the disease are living longer, healthier lives. But diabetes requires changes and considerations that permeate throughout every aspect of life. The path to self-management can feel isolating and overwhelming, especially for those who have been newly diagnosed.

The Alexa Diabetes Challenge invites innovators to submit concepts that utilize the capabilities of Amazon Alexa and the ecosystem of supporting cloud technologies to improve the experience of those newly diagnosed with type 2 diabetes.

Up to five finalists will be chosen by a panel of judges with expertise across health tech innovation, Amazon voice technology, the diabetes experience, data and ethics, and healthcare funding. Each finalist will receive $25,000 and 10,000 AWS credits, and advance to the Virtual Accelerator, during which they will receive expert mentorship as they develop their concepts into solutions. In addition, AWS will host an Innovators’ Boot Camp for the finalists at Amazon’s Seattle headquarters. At the end of the Virtual Accelerator, finalists will present their solutions in-person to the judges at Demo Day at the AWS Pop-up loft in New York City. Following Demo Day, the judges will select a winner, who will receive the $125,000 grand prize.

Interested in entering? Submit at by 5:00 PM ET on May 22, 2017.

You may also like

  • Can Intensive Medical Treatment Reverse Type 2 Diabetes?

    Type 2 diabetes can be reversed with intensive medical treatment using oral medications, insulin and lifestyle therapies, according to a study published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Hertzel C. Gerstein, MD, MSc, FRCPC, of McMaster University and Hamilton Health Sciences in Hamilton, Ontario, Canada randomly divided 83 individuals with…

  • Recent Survey Finds Many Adults with Diabetes Unaware of Their Increased Risk for Certain Serious Illnesses

    Many adults with diabetes are unaware of their increased risk for certain serious illnesses, according to a recent national, online consumer awareness survey sponsored by Merck and the American Diabetes Association, and conducted by Harris Poll. In the survey of 1,003 U.S. adults ages 18 years and older diagnosed with diabetes, respondents were twice as…